Investor Lawsuit Targets Applied Therapeutics Over Alleged Govorestat Clinical Data Deception
Investor lawsuit alleges Applied Therapeutics misled investors about Govorestat clinical trial data, leading to significant losses after FDA rejection. The suit focuses on alleged data deficiencies and dosing errors concealed from investors between January and December 2024.